Frequently Asked Questions
The market is segmented based on , By Type (Panic Disorder, Agoraphobia, Generalized Anxiety, Social Anxiety, Specific Phobia, Others), Treatment (Medications, Therapy, Others), Patients (Inpatients, Outpatients), Route of Administration (Oral, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2029.
.
The Global Anxiety Disorder Market size was valued at USD 11.00 USD Million in 2021.
The Global Anxiety Disorder Market is projected to grow at a CAGR of 5% during the forecast period of 2022 to 2029.
The major players operating in the market include Pfizer , Merck KGaA, Sanofi, Biocare Medical LLC, Lilly, Teva Pharmaceutical Industries, Mitsubishi Chemical Group Corporation, BristolMyers Squibb Company, GSK plc, Bayer AG, AstraZeneca, H. Lundbeck AS, Forest Laboratories .
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
